1-3 of 3
Blanche Anderson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long progression-free survival with venetoclax consolidation in patients with high-risk chronic lymphocytic leukemia treated with ibrutinib.

Free
Vishrut Shah, Philip Thompson, Grace Nie, Nitin Jain, Blanche Anderson, Tapan Kadia, Prithviraj Bose, Naveen Pemmaraju, Nicholas Short, Sa Wang, Jeffrey Jorgensen, Christine Peterson, William Wierda, Alessandra Ferrajoli
Journal: Blood
Blood (2025) 146 (Supplement 1): 5686.
https://doi.org/10.1182/blood-2025-5686
Published: 2025
Journal Articles

A Phase I Trial of the Small Molecule Pan-Bcl-2 Family Inhibitor GX15-070 Administered Intravenously (IV) Every 3 Weeks to Patients with Previously Treated Chronic Lymphocytic Leukemia (CLL).

Free
Susan O’Brien, MD, Thomas J. Kipps, MD, Stefan Faderl, MD, Michael Crump, MD, Michael J. Keating, MD, Blanche Anderson, Claudia Soho, Jan Bole, Ruth Turner, Jean Viallet, MD, Bruce D. Cheson, MD
Journal: Blood
Blood (2005) 106 (11): 446.
https://doi.org/10.1182/blood.V106.11.446.446
Published: 2005
Journal Articles

A Phase I/II Trial of Xcellerated T Cells™ in Patients with Chronic Lymphocytic Leukemia.

Free
Januario E. Castro, MD, William G. Wierda, MD, PhD, Thomas J. Kipps, MD, PhD, Michael J. Keating, MBBS, Jan Bole, RN, Blanche Anderson, Jayne Meyer, RN, Mark Bonyhadi, PhD, Ronald J. Berenson, MD, Mark W. Frohlich, MD
Journal: Blood
Blood (2004) 104 (11): 2508.
https://doi.org/10.1182/blood.V104.11.2508.2508
Published: 2004